AVROBIO: Combined Co to Be Nasdaq-listed, Clinical-Stage Biopharmaceutical Co Focused on Advancing Tectonic's Novel GPCR-targeted Therapeutic Proteins >AVRO
AVROBIO: Combined Co to Be Nasdaq-listed, Clinical-Stage Biopharmaceutical Co Focused on Advancing Tectonic's Novel GPCR-targeted Therapeutic Proteins >AVRO
AVROBIO：合併公司將在納斯達克上市，處於臨床階段的生物製藥公司專注於推進Tectonic的新型GPCR靶向治療蛋白 >AVRO
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊